Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Shock, Septic 1Sepsis 1Ovarian Neoplasms 1Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1

Interventions

Psychiatric Rehabilitation 3Early Intervention, Educational 3Carboplatin 3Behavior Therapy 3Surgical Procedures, Operative 2Specimen Handling 2Platinum 2Palliative Care 2Methods 2Hyperthermic Intraperitoneal Chemotherapy 2Gene Expression Profiling 2Cisplatin 2Blood Specimen Collection 2taxane 1oregovomab 1motexafin lutetium 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Touch 1Taxes 1Standard of Care 1Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 1Sodium Chloride 1Serotonin Plasma Membrane Transport Proteins 1Radiotherapy 1Propranolol 1Preoperative Exercise 1Practice Guidelines as Topic 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Fallopian Tube Neoplasms × Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization × Clear all
NCT00238342 2010-02-09

Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass

National Cancer Institute (NCI)

Phase NA Unknown
2,000 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡